Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Morales-García

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 21, 2008
Cancer stem cells and brain tumorsA Pérez Castillo, D Aguilar-Morante, J A Morales-García, et al.
British Journal of Pharmacology|May 22, 2015
PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosisL Mestre, M Redondo, F J Carrillo-Salinas, et al.
ACS Chemical Neuroscience|February 21, 2013
Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson diseaseJ A Morales-García, C Susín, S Alonso-Gil, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 21, 2008
Cancer stem cells and brain tumorsA Pérez Castillo, D Aguilar-Morante, J A Morales-García, et al.
British Journal of Pharmacology|May 22, 2015
PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosisL Mestre, M Redondo, F J Carrillo-Salinas, et al.
ACS Chemical Neuroscience|February 21, 2013
Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson diseaseJ A Morales-García, C Susín, S Alonso-Gil, et al.
Pageof 1